Basel Medical Group Ltd (BMGL) stock

BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 3/30

$0.47−0.10 (-17.54%)

Close on Nov 13, 2026Market cap $743.59KP/E –Yield –

Basel Medical EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2026 it was -0.78 SGD.

Period	Period end	Value	Change
FY2026	Jun 30, 2026	-0.78 SGD	–
FY2025	Jun 30, 2025	-0.57 SGD	-538.5%
FY2024	Jun 30, 2024	0.13 SGD	–

Parsed from the XBRL in Basel Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Jun 22, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BMGL.

Revenue growth45.2% · median -15.3%

Net margin-4.5% · median -63.1%

Advertisement
300 × 250

See a number that looks wrong?